chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The day after shot employee experienced slight nausea & weakness & hand tremors.  Symptoms lasted 2 days.  No medical Tx sought.  Symptoms resolved spontaneously.
Raised swollen approximately 1/4? hard 3? x 3? upper arm.  Felt very cold, shivering could not get warm, nauseous, weakened state.  No headache.  Still sore, feels like I have been punched.
given MMR/Flu vax 27OCT92; week of 9NOV92 began having aching joints w/swollen lymph glands in neck; taking aspirin; has not seen MD;
Individual developed body aches, chills, and fever approximately 12 hours after administration of the booster shot. Symptoms continued for 2 days.  Individual developed redness at the site of injection which continued to spread over the course of 3 days. Area was warm, hard, and swollen. Individual was prescribed Keflex.
Fatigue, pain in left shoulder, heavy menstrual bleeding 2 days after the shot despite the period just ended 1 week ago.
Vaccine vial is suppose to be diluted with 1.1ml 0.9% Sodium chloride prior to drawing up vaccine and administering vaccine. After dilution of vaccine, vial has 3 doses per vial of 3mcg/0.3mL.   Error occurred: MA prepared and administered vaccine without prior dilution of vaccine. Vaccine error was caught  by charge nurse a few hours after vaccine was administered by the MA. Pt's mother and MD was notified, per pt's mother pt is doing fine with no adverse reactions at this time.
FEVER BEGAN 1/23, THE DAY FOLLOWING FIRST MODERNA INJECTION.  I'VE HAD A FEVER BETWEEN 99-102.8 EVERY DAY SINCE THE VACCINE ALONG WITH A CONSTANT HEADACHE AND GENERALLY DON'T FEEL WELL. I'M EXPERIENCING LETHARGY AND BRAIN FOG. ALSO HAD A RASH SHOW UP ON MY CHEST - WARM TO TOUCH, BUT HAS SINCE RESOLVED. STILL FEELING QUITE UNWELL AND NONE OF MY DOCTORS KNOW WHAT TO DO.  ADVISED TO HOLD OFF ON REMICADE INFUSIONS FOR MY AUTOIMMUNE CONDITIONS AND HOLD OFF ON 2ND DOSE MODERNA, ORIGINALLY SCHEDULED FOR 2/19 AT THE SAME LOCATION.
APPROX 24 HRS AFTER INJECTION PATIENT DEVELOPED RASH TO STOMACH, UPPER CHEST AND FACE. HIS EYES HURT, HAD A HEADACHE AND STOMACH WAS UPSET, THERE WAS NO TREATMENT GIVEN AT THIS TIME.  PATIENT'S ALLERGY DR ORDEREDFOR HIM TO HAVE THIS SO PARENTS STATED THAT THEY DIDN'T WANT TO TREAT HIM AS THEY WANTED HIS BODY TO BUILD THE IMMUNITY THEY JUST WERE REPORTING HIS REACTION.
First dose administered to a 11 y/o patient; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose administered to a 11 y/o patient) in an 11-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose administered to a 11 y/o patient). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose administered to a 11 y/o patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.  HCP has enquiring about a female patient of 11years who have taken first dose of Moderna 5 days before turning to 12 years,  Now, they were suggested her to go to the pharmacy to get the second dose instead of doing it themselves and enquiring whether she can get the second dose? Or should she get Pfizer instead?".
Both shots administered on 9/29/2022, Diarrhea started 1:00am Friday morning, Rash on lower non vaccinated arm, and ankles, Friday afternoon 2pm.ish. Diarrhea  subsided Saturday evening and rash is red and itchy. Used Hydrocortisone  for the itch and getting Benadryl for the itch, to date she is about 85% back to normal.
About 2 weeks after my 2nd Covid shot (second shot was on 4/17), I began have muscle twitches throughout my entire body from head to toe.  At the beginning they were like rapid fire -- hundreds of them all day long.  It has been about 3.5 months and I am still having muscle twitches, although they have calmed down a bit.  I was referred to a neurologist by my PCP and underwent an nerve conduction test which was normal.  The neurologist was not able to determine why the twitches were happening. I believe it may be some kind of reaction to the vaccine.
Today, three days after the injection, I began to feel tingling in my upper lip and in my toes.
They all had Pfizer Covid vaccines in Feb.  Many have had the breakthrough Covid virus.; They all had Pfizer Covid vaccines in Feb.  Many have had the breakthrough Covid virus.; This is a spontaneous report from a non-contactable consumer reported for a patient. A potential AE has been reported to the Pfizer regulatory authority. A female patient of an unspecified age received an unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date in Feb2021 (age at vaccination was unknown) as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The caller was in a senior assisted living facility of 500 residents. They all had Pfizer COVID vaccines in Feb. Many have had the breakthrough COVID virus on an unspecified date in 2021. She wanted to speak to someone about doing a booster trial there, because they would be good candidates. The patient underwent lab test which included COVID test: positive (COVID-19) on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient resides at Medical Care Center.  When screened prior to COVID-19 booster vaccination the patient and facility did not not she had monoclonal antibody treatment for COVID-19 within the past 90 days for having a COVID-19 positive diagnosis.  Nurse administered Moderna booster and then the facility noted the patient had REGEN-COV monoclonal antibody treatment on 9/17/2021.  The has not yet experienced any reaction from this event.
A report has been received from a Pharmacist concerning a 12 year old, female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 01-Jan-2014. The reporter stated that the patient experienced expired FLUMIST QUADRIVALENT administered which started on 01-dec-2014. The outcome of the event of expired FLUMIST QUADRIVALENT administered is unknown. The report ws considered to be non-serious.
Chills, fever, shortness of  breath, fast heart rate for over 10 hours. Symptoms improved after 12 hours and completely gone in 36 hours.
12MAY94 f/u nausea, severe which began day p/2nd booster dose, lasted 4 days then had onset of hot, red hives on 8OCT93; seen by MD; had 3 doses in JUL92; These were post exposure boosters;
FEW TOUGH SYMPTOMS; MILD SYMPTOMS; This spontaneous report received from a patient via a company representative via social media concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number: unknown, expiry unknown) dose was not reported, administered 1 in total, on 25-MAR-2021 for prophylactic vaccination as primary vaccination (dose number in series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, following vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced few tough symptoms(unspecified) and afterwards felt fine (dose number in series 1). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. On an unspecified date, the patient recovered from few tough symptoms. The patient received booster dose of non-company suspect vaccine mrna 1273 ( form of admin, route of admin, and batch number: unknown, expiry unknown) dose was not reported, administered on 03-DEC-2021 for prophylactic vaccination (dose number in series 2).  On an unspecified date in DEC-2021, following vaccination with mrna 1273, the patient experienced mild symptoms (unspecified). (dose number in series 2) The action taken with mrna 1273 was not applicable. The outcome of mild symptoms was unknown. This report was non-serious.
This spontaneous report as received from a pharmacist refers to a 66 year old female patient. The patient's medical history and concurrent conditions were not provided. On an unknown date the patient was vaccinated with a dose of MMR II (albumin status unknown). Dose, route and lot number were not provided. No concomitant medications were reported. The pharmacist reported the titer was drawn yesterday (approximately on 14-JAN-2014). The pharmacist stated he was unsure if this client was ever vaccinated with MMR II. No adverse effects were reported. No reporter causality was provided. Additional information is not expected; The pharmacist did not want to be contacted.
Narrative: Hospital, Moderna x 3, Covid+, Lung CA with mass in right lung-stent and balloon placed, increased hypoxia, increase oxygen demand, cefipeme and doxy
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 12-JAN-2015, the patient was vaccinated with a dose of ZOSTAVAX 0.65 ml, subcutaneous that expired on 10-JAN-2015. The lot number was not available to provide at the time of the report. No adverse effect was reported. Additional information has been requested.
This spontaneous report was received from a healthcare worker and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On unknown dates, the patients was vaccinated with improperly stored doses of (Merck) VARIVAX lot # L013826, expiration date 21-APR-2017; lot # L032395, expiration date 26-AUG-2017; lot # L041207, expiration date 20-OCT-2017; lot # L041204, expiration date 20-OCT-2017; lot # L042265, expiration date 26-OCT-2017; lot # reported as L048465, expiration date 02-DEC-2017 (dose and route of administration were not reported). The administered doses experienced the temperature excursion of 8 degrees Fahrenheit for 5 days. The temperature excursion was detected by a data logger. There was no previous temperature excursion reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Inguinal lymphadenitis on the same side as vaccination. Reports also getting hit by soccer ball in the same area around the same time. Reports tenderness, swelling and inflammation to groin, that improved over 1 week. Pt still has hard lymph node about 1 cm more than 1 month after vaccination. Pt tx'd with antibiotics, which did not resolve lymphadenitis.
Patient started having body aches and chills approximately 8 after vaccination administration. Patient also reports having a fever of 101.5F. For the fever, the patient took 1 Aleve tablet and 2 Tylenol tablets over the counter. Shakes lasted for at least another hour, until over the counter analgesics began working. The patient also reported feeling some joint pain and body stiffness all over. He was able to fall asleep, but ended up waking up around 3 AM, when he checked his temperature again, and his fever fell to 99F, before falling asleep again. The patient reports no additional fever by the next day, but experienced fatigue and malaise for the next  2 days. By the 3rd day after vaccine administrationi, the patient reports symptoms fading and  feeling back to normal. The patient also reported increase injection site soreness compared to the first dose of Shingrix.
Did not feel good at all; Broke out in rash; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Did not feel good at all) and RASH (Broke out in rash) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Did not feel good at all) and RASH (Broke out in rash). At the time of the report, FEELING ABNORMAL (Did not feel good at all) and RASH (Broke out in rash) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2022-550751, MOD-2022-550427 (Patient Link).
12-15-09 swelling, redness at injection site-clear fluid leakage-saw physician who recommended Benadryl/Tylenol PRN Temp 99-101 degrees. 12-16-09 Dx of Cellulitis-Rx with Cephalexin.
PATIENT CAME IN REPORTING FEELING TIRED WITH LOW GRADE FEVER, 100.8, RED SWOLLEN LEFT ARM WHICH IS HOT TO THE TOUCH. THE SWOLLEN AREA WAS ABOUT 4 INCH X 4 INCH. PATIENT WAS ADVISED: TO TAKE TYLENOL; IF SIGNS AND SYMPTOMS DON'T GET BETTER OR GETTING WORSE, SEE A DOCTOR. CALLED PATIENT ON MONDAY TO CHECK ON; SHE STATES THAT SHE TOOK TYLENOL AND BENADRYL THAT EVENING AND IS GETTING BETTER, SWELLING HAS GONE DOWN, DIDN'T NEED TO SEE DOCTOR.
Pt received his Pfizer vaccines on 1/28/21, 2/25/21, 10/27/21 an d4/26/22. he came in for his bivalent booster dose on 10/18/22 Due to mix up of the Pfizer monovalent and bivalent vaccine- he may have gotten either the monovalent or bivalent Pfizer vaccine.
dental work done after first dose; mouth is still bothering him after first dose; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH DISORDER (dental work done after first dose) and ORAL PAIN (mouth is still bothering him after first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TOOTH DISORDER (dental work done after first dose) and ORAL PAIN (mouth is still bothering him after first dose). The patient was treated with CORTISONE for Dental disorder NOS, at an unspecified dose and frequency and IBUPROFEN for Dental disorder NOS, at an unspecified dose and frequency. At the time of the report, TOOTH DISORDER (dental work done after first dose) outcome was unknown and ORAL PAIN (mouth is still bothering him after first dose) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided. Patient had some dental work done and took pain killer. He had scheduled to received the second dose of Moderna COVID-19 Vaccine on 06Apr2021. Patient stopped taking the Ibuprofen last Tuesday.
Patient was vaccinated againist smallpox on 12 March 2003, pregnancy diagnosed on 2 April 2003 with LMP on 2 March 2003.  No unusal symptoms experienced at this time.  SUPPLEMENTAL INFO FORM COMPLETED BY OB/GYN STAFF
Headache; Sore arm; This is a spontaneous report from a non-contactable consumer (patient).   A 34 years old female patient received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) on 22Jan2021, at single dose, for COVID-19 immunisation. Relevant medical history and concomitant medications were unknown. On 23Jan2021, the patient experiencing headache and sore arm. Clinical outcome of the adverse events was unknown at time of this report.   No follow-up attempts are possible, information about lot number cannot be obtained.
Mild spotty hives, itchiness in and around the scalp, rapid heartbeat. One hour before submitting the report I had a blood pressure of 148/88 pulse of 96, took blood pressure again five minutes later and had BP of 142/82 and pulse of 97. Had to call Dr's office to confirm if I could take an antihistamine to slow down the hives and itchiness. Have take one 25mg Benadryl.
I had a negative antigen test and a positive PCR test on 12/30/2021. I woke up feeling congested with fatigue and a sore throat and tested that same day. By the end of that day I had body aches and significant fatigue. The next day I felt fine but the following day I had the body aches, fever and a cough again. I continued to feel those symptoms for nine days. It was a gradual recovery and I still have a cough after two weeks. I lost my sense of smell about five days in and it has returned after two weeks. I am still a little fatigued after two weeks. I took ibuprofen and I took Flonase.
Facial neuralgia, urticaria, & angioedema.Tx w/ antihistamines & prednisone.
55-year-old female that presents to the emergency department with a rash on her hands that has been ongoing for over a year.  Patient reports that she had eczema on her hands and has been taking over-the-counter creams.  Patient has not been seen by dermatologist.  Patient reports that a week ago she developed a rash on her chest back and legs that started several days after the Covid vaccine.  Patient denies any fever.  Patient denies any difficulty breathing.  Patient reports her first Covid vaccine was the first week of February and she had an slight rash on her chest.  Patient reports after the second Covid vaccine she developed a rash on her chest back abdomen and legs.  Patient has not been seen by her PCP.  Pt has not tried any over-the-counter medication now for this rash. Pt given prednisone and hydrocortisone cream which resolved by f/u visit but pt still has ongoing eczema predating COVID vaccine.
Allergic reaction rash 24 hours following vaccinations. Rx: ZYRTEC.
This spontaneous report was received from an 60-year-old female patient regarding herself. On 31-MAY-2012 the patient was vaccinated with ZOSTAVAX single dose vial (lot# not reported) subcutaneously. No relevant medical history reported. No concomitant medications were reported. On 03-JUN-2012 the patient developed persistent burning, tingling pain in bilateral upper and lower extremities. The patient has had a work-up approximately on an unknown date in 2012 including a Magnetic Resonance Imaging (MRI) of head as well as upper and lower back, by an unspecified neurologist and all results have been normal. Electromyogram was normal. The patient was scheduled for evaluation at the neurology department in the future. Treatment was not given for the events. Medical attention was sought for the events, the patient had an office visit. No further information provided. The reported events were not resolved at the time of this report. Additional information has been requested.
Right thigh developed large red area around the injection site. Redness noticed within 24 hours. Progressed to size of a fist in 2-3 days. On 12/1/08 was improving. Site of Dtap and IPV injections. Not painful, child was running, jumping, and displaying normal behavior during exam.
fever; chills; This case was reported by a other health professional via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, 3 days after receiving Shingrix, the patient experienced fever and chills. On an unknown date, the outcome of the fever and chills were unknown.   It was unknown if the reporter considered the fever and chills to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient received Shingrix and on day 3 presented with fever and chills.
Pt developed new type of headache 3 days after receiving vaccine that was unrelenting. Did not respond to IM dose of toradol and hydroxyzine.
Mom reports that patient has developed a rash next to the injection sight. Red, bullseye appearance. Mom states patient is reporting pain and itch. No fever.
Itchy red eyes, paroxysmal dry cough, chest tightness, sore throat: Onset approximately 3 days post vaccination. Clear rhinorrhea: 1 week after. "Oculo-respiratory Syndrome" (ORS). TX: OTC TYLENOL, dextromethorphan and phenylephrine.
I noticed throughout the first month or two after getting each shot, I would get more migraine headache than I am having; I always get a little chills and aches some days after; typically they start like later in the afternoon; I take my migraine medicine and they will go away, when I sleep in I'll be okay but then it will come back again that evening; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old patient received BNT162b2 (BNT162B2), as dose 1, single (Lot number: EW0158), as dose 2, single (Lot number: EN6207) and as dose 3 (booster), single (Lot number: FK9895) for covid-19 immunisation. The patient's relevant medical history included: "low thyroid" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE taken for thyroid disorder; LIOTHYRONINE taken for hypothyroidism. The following information was reported: MIGRAINE (non-serious), outcome "unknown", described as "I noticed throughout the first month or two after getting each shot, I would get more migraine headache than I am having"; CHILLS (non-serious), outcome "unknown", described as "I always get a little chills and aches some days after"; MIGRAINE (non-serious), outcome "unknown", described as "typically they start like later in the afternoon; I take my migraine medicine and they will go away, when I sleep in I'll be okay but then it will come back again that evening".  Additional Information: Consumer stated, "And typically they start like later in the afternoon and they usually I have to take my migraine medicine and then sometimes I wake up with it I take my migraine medicine and they will go away, when I sleep in I'll be okay but then it will come back again that evening. So it happens for a couple of days in a row and then I'm fine for a while and then the same thing repeats and it goes usually a couple of days in a row and it's more so than I would normally have my migraines."  No follow-up attempts are possible. No further information is expected.
Injection site pain; Swollen and tender left armpit lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 51-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: PAA165969), via unspecified route of administration in the left arm at 15:30 on 22Mar2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported and the patient had no known allergies. The concomitant medications were reported as no. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021, the patient experienced injection site pain, swollen and tender left armpit lymph nodes. The patient did not receive treatment for the reported events and the events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events injection site pain, swollen and tender left armpit lymph nodes was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Chills, PAINFUL body aches, low grade fever, diarrhea, trembling, profuse sweating